comparemela.com

Page 10 - Ann Chang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2021

STRASBOURG, France & LUND, Sweden (BUSINESS WIRE) Regulatory News:Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery.

Ultimovacs Begins Dosing of Second Cohort in Phase I TENDU

First patient in second cohort dosed with 400 μg of TET vaccineDSMB found no safety concerns for first cohort of three patients at 40 μg dose OSLO,.

Transgene and BioInvent to Present Preclinical Data on BT-001 Oncolytic Virus at SITC 2021

Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB ("BioInvent")

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.